APA (7th ed.) Citation

PM, L., A, S., JA, S., WS, L., J, C., DW, C., . . . JM, T. (2021). Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial. PloS one, 16(4), e0248097. https://doi.org/10.1371/journal.pone.0248097

Chicago Style (17th ed.) Citation

PM, LoRusso, et al. "Identifying Treatment Options for BRAFV600 Wild-type Metastatic Melanoma: A SU2C/MRA Genomics-enabled Clinical Trial." PloS One 16, no. 4 (2021): e0248097. https://doi.org/10.1371/journal.pone.0248097.

MLA (9th ed.) Citation

PM, LoRusso, et al. "Identifying Treatment Options for BRAFV600 Wild-type Metastatic Melanoma: A SU2C/MRA Genomics-enabled Clinical Trial." PloS One, vol. 16, no. 4, 2021, p. e0248097, https://doi.org/10.1371/journal.pone.0248097.